- Report
- April 2023
- 129 Pages
Global
From €4502EUR$4,750USD£3,761GBP
- Report
- October 2023
- 190 Pages
Global
From €4265EUR$4,500USD£3,563GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €474EUR$500USD£396GBP
- Report
- November 2024
- 84 Pages
Global
From €3500EUR$3,956USD£3,026GBP
- Report
- July 2022
- 55 Pages
Global
From €3317EUR$3,500USD£2,771GBP
- Report
- March 2025
- 215 Pages
China
From €3791EUR$4,000USD£3,167GBP
- Report
- March 2025
- 109 Pages
China
From €1706EUR$1,800USD£1,425GBP
- Report
- February 2021
- 225 Pages
Global
From €3276EUR$3,456USD£2,737GBP
Amlodipine is a calcium channel blocker used to treat high blood pressure and angina. It is a commonly prescribed cardiovascular drug, and is available in both generic and branded forms. It works by relaxing the muscles of the blood vessels, allowing them to widen and reduce the pressure of the blood flowing through them. It is also used to prevent certain types of chest pain, and can be used in combination with other medications to treat heart failure.
Amlodipine is generally well tolerated, with few side effects. Common side effects include headache, dizziness, and swelling of the ankles and feet. It is important to take the medication as prescribed, and to monitor blood pressure regularly.
The amlodipine market is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Pfizer, Novartis, Merck, and Teva Pharmaceuticals. Other companies include Mylan, Sandoz, and Sun Pharmaceuticals. Show Less Read more